부산대학교 도서관

Berry DL; Blonquist TM; Hong F; Halpenny B; Partridge AH

Patient Preference and Adherence, Vol 2015, Iss default, Pp 1587-1592 (2015)

Tarantino P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Tayob N; Harvard Medical School, Boston, MA.; Division of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Oncology Data Science Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Dang C; Memorial Sloan Kettering Cancer Center, New York, NY.; Yardley DA; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Isakoff SJ; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA.; Valero V; MD Anderson Cancer Center, Houston, TX.; Faggen M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Mulvey T; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA.; Bose R; Washington University School of Medicine, St Louis, MO.; Weckstein D; New Hampshire Oncology Hematology, Manchester, NH.; Wolff AC; Johns Hopkins Sidney Kimmel Cancer Center, Washington, DC.; Reeder-Hayes K; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Rugo HS; University of California, San Francisco, CA.; Ramaswamy B; Ohio State University Comprehensive Cancer Center, Columbus, OH.; Zuckerman D; St Luke's Mountain States Tumor Institute, Boise, ID.; Hart L; Wake Forest Baptist Health, Winston-Salem, NC.; Gadi VK; University of Illinois Cancer Center, Chicago, IL.; Constantine M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cheng K; North Shore-LIJ Cancer Institute, Lake Success, NY.; Garrett AM; Northern Light Cancer Care, Brewer, ME.; Marcom PK; Duke University School of Medicine, Durham, NC.; Albain K; Loyola University Medical Center, Maywood, IL.; DeFusco P; Hartford Healthcare Cancer Institute, Hartford, CT.; Tung N; Harvard Medical School, Boston, MA.; Beth Israel Deaconess Medical Center, Boston, MA.; Ardman B; Lowell General Hospital, Lowell, MA.; Nanda R; UChicago Medicine, Chicago, IL.; Jankowitz RC; Perelman Center for Advanced Medicine, Philadelphia, PA.; Rimawi M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX.; Abramson V; Vanderbilt-Ingram Cancer Center, Nashville, TN.; Pohlmann PR; MD Anderson Cancer Center, Houston, TX.; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.; Van Poznak C; Rogel Cancer Center, University of Michigan, Ann Arbor, MI.; Forero-Torres A; Kirklin UAB Hematology Oncology, Birmingham, AL.; Liu MC; Natera, Inc, Austin, TX.; Ruddy KJ; Mayo Clinic, Rochester, NY.; Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; DeMeo M; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Dell'Orto P; IEO European Institute of Oncology, IRCCS, Milan, Italy.; Russo L; IEO European Institute of Oncology, IRCCS, Milan, Italy.; Krause E; PathAI, Boston, MA.; Newhouse DJ; NanoString Technologies, Inc, Boston, MA.; Kurt BB; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Mittendorf EA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA.; Schneider B; Indiana University School of Medicine, Indianapolis, IN.; Prat A; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Winer EP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT.; Krop IE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT.; Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215,USA.; Harvard Medical School, Boston, MA 02115, USA.; DeMichele A; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Takano T; The Cancer Institute Hospital of JFCR, Koto City, Tokyo, 135-8550, Japan.; Rugo HS; University of California Comprehensive Cancer Center, San Francisco, CA 94143, USA.; Perou C; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Lynce F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215,USA.; Harvard Medical School, Boston, MA 02115, USA.; Parsons HA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215,USA.; Harvard Medical School, Boston, MA 02115, USA.; Santa-Maria CA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.; Rocque GB; University of Alabama at Birmingham, Birmingham, AL 35294, USA.; Yao W; Gilead Sciences, Inc., Foster City, CA 94404, USA.; Sun SW; Gilead Sciences, Inc., Foster City, CA 94404, USA.; Mocci S; Gilead Sciences, Inc., Foster City, CA 94404, USA.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215,USA.; Harvard Medical School, Boston, MA 02115, USA.; Carey LA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

Tyrus Korecki JR; Department of Psychology, UCLA, Los Angeles, CA.; Ganz PA; UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA.; Department of Health Policy and Management, UCLA Fielding School of Public Health, Los Angeles, CA.; Department of Medicine (Hematology-Oncology), David Geffen School of Medicine at UCLA, Los Angeles, CA.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Wolff AC; The Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.; Petersen L; UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA.; Crespi CM; UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA.; Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles, CA.; Bower JE; Department of Psychology, UCLA, Los Angeles, CA.; UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA.; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles, CA.; Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Arecco L; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genoa, Italy; Academic Trials Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium.; Bruzzone M; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Bas R; Department of Surgery, Universite Paris Cité, Institut Curie, Paris, France.; Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Di Meglio A; Cancer survivorship program - Molecular Predicitors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.; Bernstein-Molho R; Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center affiliated to Tel Aviv University, Tel Hashomer, Israel.; Hilbers FS; Department of Molecular Pathology, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.; Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Roentgena 5, Warsaw, Poland.; Carrasco E; Hereditary Cancer Genetics Unit, Medical oncology Department, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Punie K; Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Bajpai J; Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.; Agostinetto E; Academic Trials Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium.; Lopetegui-Lia N; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland (OH), USA.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Toss A; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Modena, Italy; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Centre, Lyon, France; unite INSERM U1290 RESHAPE, Claude Bernard Lyon 1 University, Lyon.; Curigliano G; European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.; Renaud T; Cancer Genetics Unit, Bergonie Institute, Bordeaux, France.; Ferrari A; Hereditary Breast and Ovarian Cancer (HBOC) Unit and General Surgery 3 - Senology, Surgical Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy & University of Pavia, Italy.; Paluch-Shimon S; Breast Oncology Unit, Sharett Institute of oncology, Hadassah University Hospital; Faculty of Medicine, Hebrew University, Jerusalem, Israel.; Fruscio R; U.O. Gynecology, Department of Medicine and Surgery, University of Milan-Bicocca, IRCCS San Gerardo dei Tintori, Monza, Italy.; Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Wong SM; Stroll Cancer Prevention Centre and Jewish General Hospital Department of Surgery and Oncology, McGill University Medical School, Montreal, Canada.; Vernieri C; Medical Oncology Department, Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Oncology and Hematology-Oncology Department, University of Milan, Milano, Italy.; Couch FJ; Department of Oncology, Mayo Clinic College of Medicine, Rochester (MN), USA.; Dieci MV; Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova, Padova, Italy; Oncologia 2, Istituto Oncologico Veneto IOV-IRCCS, via Gattamelata 64, Padova, Italy.; Matikas A; Department of Oncology/Pathology, Karolinska Institute and Breast Center, Karolinska University Hospital, Stockholm, Sweden.; Rozenblit M; Yale University, Department of Medical Oncology, New Haven (CT), USA.; Aguilar-Y Méndez D; Tecnologico de Monterrey, Breast Cancer Center, Hospital Zambrano Hellion - TecSalud, Monterrey, Mexico.; De Marchis L; Division of Medical Oncology, Department of Radiological, Oncological and Pathological Sciences, 'La Sapienza' University of Rome, Rome, Italy; Oncology Unit, Department of Hematology, Oncology and Dermatology, Umberto I Policlinico di Roma, Italy.; Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy;; Department of Medicine, University of Udine, Udine, Italy.; Fabi A; Precision Medicine Unit in Senology, Scientific Directorate, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Roma, Italy.; Graff SL; Lifespan Cancer Institute, Legorreta Cancer Center at Brown University, Providence, RI, USA.; Witzel I; Department of Gynaecology, University Medical Center Hamburg, Hamburg, Germany & Department of Gynecology, University of Zurich, Zurich, Switzerland.; Rodriguez A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Fontana A; U.O. Oncologia Medica 2 Universitaria, Azienda Ospedaliero Universitaria Pisana, Ospedale Santa Chiara, Pisa, Italy.; Pesce R; Reproductive medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.; Duchnowska R; Department of Oncology, Military Institute of Medicine, National Research Institute, Warsaw, Poland.; Pais HL; Department of Medical Oncology, Centro Hospitalar Universitário Lisboa Norte-Hospital de Santa Maria, Lisbon, Portugal.; Sini V; Medical Oncology, Centro Oncologico Santo Spirito-Nuovo Regina Margherita, ASL Roma 1, Rome, Italy.; Sokolović E; Oncology Clinic, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.; de Azambuja E; Academic Trials Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium.; Ceppi M; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Blondeaux E; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Lambertini M; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genoa, Italy; Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: matteo.lambertini@unige.it.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Zhang BX; Harvard Medical School, Boston, MA, USA.; Brantley KD; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA.; Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Rosenberg SM; Weill Cornell Medicine, New York, NY, USA.; Kirkner GJ; Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Collins LC; Harvard Medical School, Boston, MA, USA.; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Ruddy KJ; Mayo Clinic, Rochester, MN, USA.; Tamimi RM; Weill Cornell Medicine, New York, NY, USA.; Schapira L; Stanford University, Stanford, CA, USA.; Stanford Cancer Institute, Stanford, CA, USA.; Borges VF; University of Colorado Cancer Center, Denver, CO, USA.; Warner E; Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Come SE; Harvard Medical School, Boston, MA, USA.; Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Winer EP; Yale Cancer Center, New Haven, CT, USA.; Bellon JR; Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.; Partridge AH; Harvard Medical School, Boston, MA, USA. ann_partridge@dfci.harvard.edu.; Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. ann_partridge@dfci.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. ann_partridge@dfci.harvard.edu.

Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Mayer EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Ren Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Mahtani R; Department of Medical Oncology, Miami Cancer Institute, Miami, FL.; Ma C; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO.; DeMichele A; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Cristofanilli M; Department of Medical Oncology, Weill Cornell Medicine, New York, NY.; Meisel J; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.; Miller KD; Hematology/Oncology Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN.; Abdou Y; Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Riley EC; Department of Medicine, Brown Cancer Center, University of Louisville Health, Louisville, KY.; Qamar R; Aurora Cancer Care, Milwaukee, WI.; Sharma P; Department of Medical Oncology, University of Kansas Medical Center, Westwood, KS.; Reid S; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.; Sinclair N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Faggen M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Block CC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Ko N; Department of Medical Oncology, Boston Medical Center, Boston, MA.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Chen WY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; DeMeo M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Attaya V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Okpoebo A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Alberti J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Liu Y; Pfizer, La Jolla, CA.; Gauthier E; Pfizer, La Jolla, CA.; Burstein HJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Regan MM; Harvard Medical School, Boston, MA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Sedrak MS; Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, USA. Electronic address: msedrak@mednet.ucla.edu.; Lee MK; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA.; Ji J; Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA, USA.; Satele DV; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA.; Freedman RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Poorvu PD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; O'Connor T; Department of Breast Oncology, Moffitt Cancer Center, Tampa, Florida, USA.; Williams GR; Department of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.; Hopkins JO; SCOR/NCORP/Novant Health Cancer Institute, Winston-Salem, NC, USA.; Muss HB; Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.; Cohen HJ; Department of Medicine, Duke University School Medical Center, Durham, NC, USA.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Carey LA; Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.; Chow SL; Alliance Protocol Operations Office, Chicago, IL, USA.; Subbiah N; Alliance Protocol Operations Office, Chicago, IL, USA.; Le-Rademacher J; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA.; Jatoi A; Department of Oncology, Mayo Clinic, Rochester, MN, USA.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101534770 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-4076 (Electronic) Linking ISSN: 18794068 NLM ISO Abbreviation: J Geriatr Oncol Subsets: MEDLINE

Cao C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Yang L; Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, AB, Canada.; Nohria A; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.; Mayer EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ligibel JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

Krecko LK; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; Neuman HB; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; Department of Surgery, University of Wisconsin Carbone Cancer Center, Madison, WI, USA.; Greenberg CC; Department of Surgery, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.; Wilke LG; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; Department of Surgery, University of Wisconsin Carbone Cancer Center, Madison, WI, USA.; Hanlon BM; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; Department of Biostatistics and Medical Informatics, Madison, WI, USA.; Edge SB; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center and University at Buffalo, Buffalo, NY, USA.; Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, MN, USA.; Partridge AH; Department of Medical Oncology, Dana Farber/Partners CancerCare, Boston, MA, USA.; Le-Rademacher J; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.; Yang DY; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; Havlena J; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; R Schumacher J; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. jessica_schumacher@med.unc.edu.; Department of Surgery, University of Wisconsin Carbone Cancer Center, Madison, WI, USA. jessica_schumacher@med.unc.edu.; Department of Surgery, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA. jessica_schumacher@med.unc.edu.

Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE